- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Alberto Ascherio Addresses Smoking and MS
Alberto Ascherio, MD, DrPh, professor of epidemiology and nutrition at the Harvard T. H. Chan School of Public Health and professor of medicine at the Harvard Medical School, discusses the current state of knowledge on smoking and multiple sclerosis (MS) risk and the risk of MS progression.
Alberto Ascherio, MD, DrPh, professor of epidemiology and nutrition at the Harvard T. H. Chan School of Public Health and professor of medicine at the Harvard Medical School, discusses the current state of knowledge on smoking and multiple sclerosis (MS) risk and the risk of MS progression.
Transcript
What is the current state of knowledge about smoking and MS?
The data on risk are quite compelling. Smokers have about a two-fold higher risk of developing MS than nonsmokers. I mean heavy or regular smokers. The association with MS progression is more complex. Smoking is associated with comorbidities, of course: cardiovascular disease and several other adverse health effects. It seems to accelerate also the progression from relapsing/remitting to progressive MS.
Alopecia Areata Treatment Advancements and Emerging Technology
November 4th 2024Kristen Whitney, DO, FAAD, dermatologist at Allegheny Health Network, highlighted recent breakthroughs in treating alopecia areata, focusing on the effectiveness of Janus kinase inhibitors and the ongoing challenges related to insurance coverage and patient access.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
